Ventiv Health Communications, New York, the former Snyder Healthcare Communications that was recently spun off into an independent public company, said this week it will create a migraine campaign for Glaxo Wellcome.
The integrated marketing program, called e.Scape Migraine, will target physicians and focus on migraine diagnosis and treatment education.
Separately, Ventiv and Snyder share prices both have performed poorly, hitting 52-week lows consistently since the September 28 spin-off occurred. Snyder Communications did not return calls seeking comment. Snyder Communications’ stock price was $12.50 as of Oct. 15; Ventiv’s was $7.88 the same day.
